Gala vs WeightWatchers (Sequence): Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
WeightWatchers (Sequence) beats Gala overall, scoring 7.4/10 vs 7.2/10. Gala is more affordable at $149/mo vs $423/mo. Choose Gala for tirzepatide-first patients who want a low-cost compounded pa. Choose WeightWatchers (Sequence) for users who want glp-1 medication combined with the weightwatc.
A side-by-side comparison of Gala and WeightWatchers (Sequence) covering pricing, scores, medication types, insurance, and more to help you decide.
Gala
#40 of 49Telehealth platform focused on compounded tirzepatide — both microdose and full-dose tiers — alongside a brand-name semaglutide (Ozempic) path and a 'coming soon' Wegovy pill. Operated by AI Coaching, Inc. (Wilmington, DE), backed by OpenLoop-affiliated medical groups (a recognized US telehealth backend) and LegitScript verified. Differentiator: a dedicated 'Gala GLP-1 Tracker' iOS + Android app for in-treatment dosing, weight, and side-effect logging.
Visit GalaWeightWatchers (Sequence)
#29 of 49WeightWatchers' clinical weight management arm (acquired from Sequence). Membership is tiered: 12-month plan first month $149-$299 depending on tier, then $74/mo ongoing for months 2-12; shorter plans are higher per-month. Medication billed separately: $199/mo intro for 2 months, then $349/mo ongoing. Lineup includes Saxenda (liraglutide brand), Wegovy, Zepbound, and compounded semaglutide/tirzepatide.
Visit WeightWatchers (Sequence)| Feature | Gala | WeightWatchers (Sequence) |
|---|---|---|
| Our Score | 7.2/10 | 7.4/10 |
| Starting Price | $149/mo | $423/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | Yes |
| Best For | Tirzepatide-first patients who want a low-cost compounded path (microdose $149/mo or full-dose $179-199/mo) plus a dedicated iOS + Android tracker app for daily progress logging | Users who want GLP-1 medication combined with the WeightWatchers program and community — $74 ongoing membership (on 12-month plan, $149-$299 first month) + $349 ongoing medication = $423/mo all-in |
| Ranking | #40 | #29 |
Pros & Cons Compared
Gala
Pros
- +Microdose compounded tirzepatide at $149/mo — the cheapest microdose tirz on a tracked telehealth platform; full-dose compounded tirzepatide at $179/mo (yearly plan) or $199/mo (3-month plan)
- +Dedicated 'Gala GLP-1 Tracker' on BOTH iOS and Android — first-party in-treatment logging is uncommon among compounded-only platforms
- +OpenLoop-affiliated medical groups + LegitScript verification provide third-party accountability that many compounded-only platforms lack
- +All 50 states, free shipping, no insurance required, 24/7 patient support claimed
Cons
- −Brand-name Ozempic pricing ($1,299/mo) is materially above market — NovoCare direct pricing for Wegovy is $349/mo, Hers offers Wegovy at $149/mo via the 2026 Novo Nordisk partnership
- −Tirzepatide-only on the compounded side — compounded semaglutide is NOT offered, narrower medication menu than peers like Maximus, Ro, or Henry Meds
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness — verify your specific dose and batch with each refill
- −Initial consultation typically a sync video visit, but ongoing follow-ups and questions are chat-based (no scheduled ongoing video access) — and no published labs, no named medical director, no specialty obesity oversight
- −Restrictive refund policy — Gala's published terms state 'IN NO EVENT SHALL YOU BE ISSUED A REFUND UPON CANCELLATION OF THE SUBSCRIPTION SERVICES' with a narrow exception for provider-initiated medical disqualification. No money-back guarantee. Read the published policy at galaglp1.com/refund-policy before enrolling on a commitment plan
- −Newer brand under AI Coaching, Inc. (founded 2024 per LinkedIn) — limited public company history; founders, founding year, and named medical director not publicly disclosed on galaglp1.com itself
WeightWatchers (Sequence)
Pros
- +Combines GLP-1 medication with WeightWatchers' proven points system and community support
- +Insurance accepted for medication — can reduce costs significantly with qualifying plans
- +Decades of brand trust and weight loss expertise applied to clinical medication management
- +Access to WW community, workshops, and digital tools alongside medication
Cons
- −$269/mo without insurance is expensive for what's included clinically
- −The WW program integration adds complexity that medication-only users won't value
- −The Sequence acquisition is still integrating — some operational inconsistencies remain
- −Less medication flexibility than pure-play GLP-1 platforms
Our Verdict
WeightWatchers (Sequence) edges out Gala with a score of 7.4/10 vs 7.2/10. If budget is your priority, Gala starts at $149/mo compared to WeightWatchers (Sequence)'s $423/mo. WeightWatchers (Sequence) accepts insurance, which can significantly reduce your out-of-pocket costs. Choose Gala if you want: tirzepatide-first patients who want a low-cost compounded path (microdose $149/mo or full-dose $179-199/mo) plus a dedicated ios + android tracker app for daily progress logging. Choose WeightWatchers (Sequence) if you want: users who want glp-1 medication combined with the weightwatchers program and community — $74 ongoing membership (on 12-month plan, $149-$299 first month) + $349 ongoing medication = $423/mo all-in.
Still undecided? Editor's #1 Overall Pick
Embody
$299/mo · 7.3/10 · Compounded
If neither Gala nor WeightWatchers (Sequence) feels like the right fit, our overall #1 pick across all 49 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.
Read Full Reviews
Related comparisons
Other matchups readers comparing Gala or WeightWatchers (Sequence) tend to look at next.
- Gala vs TMates$158/mo
- Gala vs FeelGood$149/mo
- Gala vs Oak Longevity$130/mo
- WeightWatchers (Sequence) vs Sprout Health$249/mo
- WeightWatchers (Sequence) vs Enhance MD$212/mo
- WeightWatchers (Sequence) vs Fridays$249/mo